These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29303791)

  • 1. Role of DNA copy number variation in dyslipidemias.
    Iacocca MA; Hegele RA
    Curr Opin Lipidol; 2018 Apr; 29(2):125-132. PubMed ID: 29303791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in finding pathogenic DNA copy number variations in dyslipidemia.
    Iacocca MA; Dron JS; Hegele RA
    Curr Opin Lipidol; 2019 Apr; 30(2):63-70. PubMed ID: 30664016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Dyslipidemia and Ischemic Heart Disease.
    Sharma K; Baliga RR
    Curr Cardiol Rep; 2017 May; 19(5):46. PubMed ID: 28429242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number variation in metabolic phenotypes.
    Lanktree M; Hegele RA
    Cytogenet Genome Res; 2008; 123(1-4):169-75. PubMed ID: 19287152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the molecular biology of dyslipidemias.
    Ramasamy I
    Clin Chim Acta; 2016 Feb; 454():143-85. PubMed ID: 26546829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins.
    Faiz F; Hooper AJ; van Bockxmeer FM
    Crit Rev Clin Lab Sci; 2012; 49(1):1-17. PubMed ID: 22214202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of genetic testing in dyslipidaemia.
    Berberich AJ; Hegele RA
    Pathology; 2019 Feb; 51(2):184-192. PubMed ID: 30558903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
    Momtazi AA; Banach M; Pirro M; Stein EA; Sahebkar A
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):224-233. PubMed ID: 28534160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of the molecular basis of familial hypercholesterolemia and other inherited dyslipidemias.
    Kwiterovich PO
    Circulation; 2011 Mar; 123(11):1153-5. PubMed ID: 21382891
    [No Abstract]   [Full Text] [Related]  

  • 14. Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
    Iacocca MA; Wang J; Sarkar S; Dron JS; Lagace T; McIntyre AD; Lau P; Robinson JF; Yang P; Knoll JH; Cao H; McPherson R; Hegele RA
    Can J Cardiol; 2018 Oct; 34(10):1316-1324. PubMed ID: 30269829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.
    Marmontel O; Charrière S; Simonet T; Bonnet V; Dumont S; Mahl M; Jacobs C; Nony S; Chabane K; Bozon D; Janin A; Peretti N; Lachaux A; Bardel C; Millat G; Moulin P; Marçais C; Di Filippo M
    Clin Genet; 2018 Jul; 94(1):132-140. PubMed ID: 29572815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia.
    Hegele RA
    Genome; 2006 Nov; 49(11):1343-50. PubMed ID: 17426749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
    Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T
    Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.
    Punzalan FE; Sy RG; Santos RS; Cutiongco EM; Gosiengfiao S; Fadriguilan E; George P; Laurie A
    J Atheroscler Thromb; 2005; 12(5):276-83. PubMed ID: 16205024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA microarray for the detection of point mutations and copy number variation causing familial hypercholesterolemia in Europe.
    Stef MA; Palacios L; Olano-Martín E; Foe-A-Man C; van de Kerkhof L; Klaaijsen LN; Molano A; Schuurman EJ; Tejedor D; Defesche JC
    J Mol Diagn; 2013 May; 15(3):362-72. PubMed ID: 23537714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.